Dissolvable Microneedle-Mediated Transcutaneous Delivery of Tetanus Toxoid Elicits Effective Immune Response

Transcutaneous immunization using a microneedle device presents a promising alternative to syringe-based injection of vaccines. The aim of this study was to investigate the effective immune response elicited after application of tetanus toxoid antigen-loaded dissolvable microneedles (TT-MN) in mice model. Dissolvable microneedles were prepared using 20% w/v of polyvinyl alcohol and polyvinyl pyrrolidone polymer mixture by micromolding technique. TT-MN were prepared by addition of tetanus toxoid to polymer mixture before casting microneedles. TT-MN were characterized using texture analyzer, stereomicroscope, and scanning electron microscope. Tetanus toxoid loading was found to be 77 ± 2 μg per microneedle array. Confocal microscopic analysis showed that the microneedles penetrated to a depth of 130 μm inside mouse skin. Complete dissolution of microneedles was achieved within 1 h after insertion in skin. Immunization studies in Swiss albino mice demonstrated significantly (p < 0.001) greater IgG, IgG1, and IgG2a antibody titers for TT-MN and intramuscular injection groups compared with naïve control. Splenocyte proliferation assay confirmed effective re-stimulation on exposure to tetanus toxoid in microneedle treatment groups. Taken together, TT-MN can be developed as minimally invasive system for transcutaneous delivery of tetanus toxoid antigen.

[1]  Jung-Hwan Park,et al.  Polymer microneedles for transdermal drug delivery , 2013, Journal of drug targeting.

[2]  Samir Mitragotri,et al.  Transdermal immunomodulation: Principles, advances and perspectives☆ , 2018, Advanced drug delivery reviews.

[3]  Michel Cormier,et al.  Microneedle-based vaccines. , 2009, Current topics in microbiology and immunology.

[4]  Robert O. Williams,et al.  An update on coating/manufacturing techniques of microneedles , 2018, Drug Delivery and Translational Research.

[5]  Robert Langer,et al.  Transdermal drug delivery , 2008, Nature Biotechnology.

[6]  Vatika Gupta,et al.  Novel application of trimethyl chitosan as an adjuvant in vaccine delivery , 2018, International journal of nanomedicine.

[7]  R. Kaushik,et al.  Calcium phosphate nanoparticles for transcutaneous vaccine delivery. , 2013, Journal of biomedical nanotechnology.

[8]  M. Thibaudon,et al.  Calcium phosphate: a substitute for aluminum adjuvants? , 2017, Expert review of vaccines.

[9]  M. Roberts,et al.  Topical Nano and Microemulsions for Skin Delivery , 2017, Pharmaceutics.

[10]  Jung-Hwan Park,et al.  Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.

[11]  Yeu‐Chun Kim,et al.  Microneedle patches for vaccine delivery , 2013, Clinical and experimental vaccine research.

[12]  Karmen Cheung,et al.  Microneedles for drug delivery: trends and progress , 2016, Drug delivery.

[13]  Ryan F. Donnelly,et al.  Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development , 2016 .

[14]  Maelíosa T. C. McCrudden,et al.  The role of microneedles for drug and vaccine delivery , 2014, Expert opinion on drug delivery.

[15]  T. Morcol,et al.  Calcium Phosphate Nanoparticle Adjuvant , 2000, Clinical Diagnostic Laboratory Immunology.

[16]  Sanyog Jain,et al.  Immunostimulatory effect of tetanus toxoid loaded chitosan nanoparticles following microneedles assisted immunization. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[17]  Ryan F. Donnelly,et al.  Successful application of large microneedle patches by human volunteers , 2017, International journal of pharmaceutics.

[18]  Kaushalkumar Dave,et al.  Microneedles in the clinic. , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[19]  B. Weinberger Adult vaccination against tetanus and diphtheria: the European perspective , 2017, Clinical and experimental immunology.

[20]  S. Nakagawa,et al.  Development and Clinical Study of a Self-Dissolving Microneedle Patch for Transcutaneous Immunization Device , 2013, Pharmaceutical Research.

[21]  Maelíosa T. C. McCrudden,et al.  Microneedles for intradermal and transdermal drug delivery. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  Yeu‐Chun Kim,et al.  Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery , 2016, Expert opinion on drug delivery.

[23]  Shubhmita Bhatnagar,et al.  Corneal delivery of besifloxacin using rapidly dissolving polymeric microneedles , 2018, Drug Delivery and Translational Research.

[24]  N. Petrovsky Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs , 2015, Drug Safety.

[25]  M. Prausnitz,et al.  Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Shubhmita Bhatnagar,et al.  Dissolvable microneedle patch containing doxorubicin and docetaxel is effective in 4T1 xenografted breast cancer mouse model. , 2019, International journal of pharmaceutics.

[27]  N. Kollias,et al.  Infant Skin Microstructure Assessed In Vivo Differs from Adult Skin in Organization and at the Cellular Level , 2010, Pediatric dermatology.

[28]  J. Robinson Physiological Pharmaceutics—Barriers to Drug Absorption , 2003 .

[29]  J. Bouwstra,et al.  Dissolving Microneedle Patches for Dermal Vaccination , 2017, Pharmaceutical Research.

[30]  Clive G. Wilson,et al.  Physiological Pharmaceutics: Barriers to Drug Absorption , 2000 .

[31]  Mark R. Prausnitz,et al.  Dissolving Polymer Microneedle Patches for Influenza Vaccination , 2010, Nature Medicine.

[32]  Eneko Larrañeta,et al.  Microarray patches: potentially useful delivery systems for long-acting nanosuspensions. , 2017, Drug discovery today.

[33]  Priyanka Ghosh,et al.  Challenges and opportunities in dermal/transdermal delivery. , 2010, Therapeutic delivery.

[34]  T. Bowersock,et al.  Current opportunities and challenges in intradermal vaccination. , 2015, Therapeutic delivery.

[35]  Mark R Prausnitz,et al.  Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin. , 2017, Annual review of chemical and biomolecular engineering.

[36]  S. Mitragotri,et al.  Delivery Systems for Intradermal Vaccination , 2011, Current topics in microbiology and immunology.

[37]  Ryan F. Donnelly,et al.  Novel bilayer dissolving microneedle arrays with concentrated PLGA nano‐microparticles for targeted intradermal delivery: Proof of concept , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[38]  C. Thwaites,et al.  Eradication of tetanus , 2015, British medical bulletin.

[39]  P. Kumari,et al.  Zein Microneedles for Localized Delivery of Chemotherapeutic Agents to Treat Breast Cancer: Drug Loading, Release Behavior, and Skin Permeation Studies , 2018, AAPS PharmSciTech.

[40]  Yohei Mukai,et al.  Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Shubhmita Bhatnagar,et al.  Zein Microneedles for Transcutaneous Vaccine Delivery: Fabrication, Characterization, and in Vivo Evaluation Using Ovalbumin as the Model Antigen , 2017, ACS omega.

[42]  Kee-Jong Hong,et al.  Microneedles: quick and easy delivery methods of vaccines , 2017, Clinical and experimental vaccine research.